Oncternal Therapeutics, Inc. Analytics - Traffic, Statistics and Competitor Tracking


Oncternal Therapeutics, Inc. Website Screenshot

http://www.oncternal.com

Oncternal Therapeutics, Inc. Company Intro

Oncternal Therapeutics is a clinical-stage oncology company developing a diverse pipeline of treatments for cancers with critical unmet medical need. We’re committed to translate pioneering areas of cancer research into approved therapies that can be used to treat multiple cancer types.

Industry

Healthcare

Oncternal Therapeutics, Inc. Headquaters

12230 El Camino Real
San Diego,92130
United States


Oncternal Therapeutics, Inc. Share price

22 Oct 2020 02:15 GMT

$1.7000

0.01 (0.59 %)


Oncternal Therapeutics, Inc. Market cap

$36.841 M


WMC RANKING

2020

Oncternal Therapeutics, Inc. # 205

Biotechnology



Latest Oncternal Therapeutics, Inc. News

News 20 Oct 2020

The Daily Biotech Pulse: Aptinyx Jumps On Positive Readout ...

Forma Therapeutics Holdings Inc (NASDAQ: FMTX). Immunomedics, Inc. (NASDAQ: ... Oncternal Therapeutics Inc (NASDAQ: ONCT). Opthea Limited (NASDAQ: ...

News 20 Oct 2020

The Daily Biotech Pulse: Aptinyx Jumps On Positive Readout ...

Forma Therapeutics Holdings Inc (NASDAQ: FMTX). Immunomedics, Inc. (NASDAQ: ... Oncternal Therapeutics Inc (NASDAQ: ONCT). Opthea Limited (NASDAQ: ...

News 20 Oct 2020

The Daily Biotech Pulse: Aptinyx Jumps On Positive Readout ...

Cara Therapeutics Inc (NASDAQ: CARA) and Vifor Pharma announced the signing of a license agreement for the commercialization of Korsuva injection for the ...

WMC Market Score


WMC Market to Revenue Score


Revenue Total Social Followers Total Social Posts Search Volume Digital Footprint Size Digital change (New Pages) WMC Market Score
Oncternal Therapeutics, Inc. 0.04 0 0 0 0 0 0
Alexion Pharmaceuticals, Inc. 100 13.19 100 0 0 0 100
Vertex Pharmaceuticals Incorporated 97.58 100 4.12 0 0 0 91.99
3SBio Inc. 96.05 0 0 0 0 0 0
Incyte Corporation 40.27 14.26 7.26 0 0 0 19.01

Oncternal Therapeutics, Inc. Market Financials


Revenue, Expenses, Profit


Company Revenue Expense Profit Market Cap WMC Sector Score
Oncternal Therapeutics, Inc. $2,425 $35,533 $-34,188 $36.841M 205
Alexion Pharmaceuticals, Inc. $5,536,800 $2,523,000 $846,100 $25.904B 1
Vertex Pharmaceuticals Incorporated $5,402,685 $2,634,428 $2,080,775 $55.058B 2
3SBio Inc. ¥5,318,091 ¥3,085,221 ¥973,717 ¥19.953B 3
Incyte Corporation $2,229,409 $1,622,822 $446,906 $19.377B 4

Market Analytics


Company Search vs Top 4 Industry Competitors



Total Oncternal Therapeutics, Inc. Social Followers vs Top 4 Industry Competitors



Oncternal Therapeutics, Inc. Post vs Top 4 Industry Competitors